Zobrazeno 1 - 2
of 2
pro vyhledávání: '"H. J. Bjørkekjær"'
Autor:
H J Bjørkekjær, C Bruni, P E Carreira, P Airò, C Simeón-Aznar, M Truchetet, A Giollo, A Balbir-Gurman, M Martin, C Denton, A Gabrielli, H Fretheim, I Barua, H Bitter, Ø Midtvedt, K Broch, A K Andreassen, Y Tanaka, G Riemekasten, U Müller-Ladner, M Matucci Cerinic, I Castellví, E Siegert, E Hachulla, O Distler, A Hoffmann-Vold
Publikováno v:
13.01 - Pulmonary hypertension.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e4aaafc51bb39ce47ea3a4c3a29168d
https://doi.org/10.1183/13993003.congress-2022.943
https://doi.org/10.1183/13993003.congress-2022.943
Autor:
M. Scheidegger, A. Garaiman, C. Mihai, M. O. Becker, R. Dobrota, C. Bruni, S. Jordan, H. Fretheim, Ø. Midtvedt, H. J. Bjørkekjær, I. Barua, A. M. Hoffmann-Vold, O. Distler, M. Elhai
Publikováno v:
Annals of the Rheumatic Diseases. 81:735.2-736
BackgroundInterstitial lung disease (ILD) is the leading cause of death in systemic sclerosis (SSc). European consensus guidelines consider that some patients with mild disease might not need pharmacological treatment (1). Up to now, the disease char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8af24e4e8220a685eab588311dae450d
https://doi.org/10.1136/annrheumdis-2022-eular.2495
https://doi.org/10.1136/annrheumdis-2022-eular.2495